top of page

What Is an FDA Recall? Complete Crisis Prevention Guide 2025

  • Writer: Beng Ee Lim
    Beng Ee Lim
  • 2 days ago
  • 8 min read

An FDA recall is the agency's term for when manufacturers must correct or remove defective medical devices that violate federal law. Medical device recalls have been trending upwards with 1,059 device events logged in 2024—an 8.6 % jump over 2023 and the highest total in four years. High-profile recalls regularly wipe out billions in market value—case studies show double-digit share-price drops when the defect is severe.


Quick Answer: An FDA recall happens when medical device manufacturers must fix or remove products that violate FDA law and pose health risks. Class I FDA recalls mean reasonable chance of death/serious injury, Class II may cause temporary harm, Class III are minor violations. Most are voluntary, but FDA can force recalls if companies refuse to act.


This guide covers everything Medtech companies need to prevent FDA recalls, respond to crises, and navigate the agency's enforcement.


What Is an FDA Recall? Complete Crisis Prevention Guide 2025



What Is an FDA Recall?


An FDA medical-device recall is the manufacturer’s own action—either correcting a product already in the field or removing it from commerce—to fix a violation of FDA law that could harm patients. The agency’s rule of thumb: if the device is defective, poses a health risk, or both, it must be recalled.

Pro tip: “Recall” does not automatically mean “stop using the product.” Many recalls are corrections—a firmware update, a labeling change, a quick calibration—performed right where the device sits. Only the most serious defects require pulling units back.

Voluntary first, mandatory if necessary


  • 99 % of recalls start voluntarily under 21 CFR 7; FDA and the company agree on the fix and public notice.

  • If a manufacturer refuses and patient safety is at stake, FDA can issue a mandatory recall order through 21 CFR 810 (authority §518(e) FD&C Act). That step is rare but real.



The Three Types That Determine Your Company's Fate


FDA Recall vs. Correction vs. Removal:


Correction: Repair, modification, adjustment, relabeling, destruction, or inspection (including patient monitoring) of a product without its physical removal to some other location.


Removal: The physical removal of a device from its point of use to some other location for repair, modification, adjustment, relabeling, destruction, or inspection.


Market Withdrawal: A firm's removal or correction of a distributed product which involves a minor violation that would not be subject to legal action by the FDA.


The Three Types That Determine Your Company's Fate




EMERGENCY: If You Think You Have an FDA Recall Situation


DO THIS IMMEDIATELY:

  1. Stop distribution of affected lots/models

  2. Assemble crisis team (regulatory, legal, operations, communications)

  3. Document everything - all communications, decisions, timelines

  4. Contact regulatory counsel before calling FDA

  5. Assess patient safety risk - this determines everything else


The speed of your response can mean the difference between a manageable correction and a company-ending crisis.




How to Prevent FDA Recalls: Strategies That Save Companies


Prevention is infinitely cheaper than managing recalls. Here's how smart medtech companies avoid catastrophic mistakes.


1. Build Early Warning Systems


Monitor these signals that predict FDA recall risk:


  • Customer Complaints: A costly recall can become unmanageable if the manufacturer can't track unique product identifiers or customer complaints. Track complaint trends, not just individual reports.

  • Service Reports: Pattern analysis of field service calls often reveals systemic issues before they become recalls.

  • Social Media Monitoring: Patients and healthcare providers increasingly discuss device problems online before filing formal complaints.



2. Master Software Validation (The #1 Recall Trigger)


Five years ago, the leading cause of recall were device design issues and product control. According to analysts, the trend toward software issues reflects the increasing complexity of medical device software.


  • Critical Focus Areas:

    • Cybersecurity testing and validation

    • Software update procedures

    • User interface design flaws

    • Integration with hospital systems



3. Implement Bulletproof Manufacturing Controls


Recent FDA recall examples show where companies fail:


Smiths Medical ProPort plastic implantable ports were pulled from circulation after receiving reports of a manufacturing defect linked to parts of the port splitting either before, during, or after implantation. There have been two reported injuries.


Fresenius Kabi has pulled an incorrectly assembled line of its Ivenix LVP Blood Products Administration Set. If used, patients could be infused with unfiltered blood.



4. Create Rapid Response Protocols


When issues surface, every hour matters. Establish procedures for:

  • Immediate risk assessment

  • Cross-functional team activation

  • FDA communication strategy

  • Customer notification systems



5. Understand Global Recall Impact


57% of medical device recalls are nationwide. Recalls of products with international distribution represented 36% of the total. International recalls multiply complexity and costs exponentially.





Class I vs Class II vs Class III FDA Recalls: What Each Really Means


FDA assigns recall classifications based solely on patient risk, not device complexity. Understanding these differences determines your response strategy.



Class I FDA Recalls: Maximum Danger Zone


Class I - a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.


2025 Class I Examples That Should Terrify You:


Becton, Dickinson and Company's esophagogastric balloon tamponade tubes after customers complained they struggled to remove the device's plastic plugs. Two serious injuries and a death were reported as of May 23.


Bausch + Lomb warned customers not to use certain models of its enVista intraocular lenses after increased reports of users developing toxic anterior segment syndrome. FDA data indicates there have been at least 44 reported cases since 2020, with the majority (35) reported in 2025.


The Alarming Trend: Life-threatening Class I recalls have increased since 2016. Between 2016 and 2017, there was a 64.76% increase in device unit recalls, from a quarterly average of 310,158 units to 511,017 units.



Class II FDA Recalls: Temporary Harm (But Still Dangerous)


Class II - a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.


Most medical device recalls are class II recalls. This is the category most medtech companies will face.


Real Example: Baxter Healthcare solution sets with duo vent spikes because they weren't properly assembled. Medication may not get properly delivered to a patient's bloodstream or patients could lose blood with these faulty sets.



Class III FDA Recalls: Minor but Still Costly


Class III - a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.


These involve labeling, packaging, or minor regulatory violations. Don't let "minor" fool you—they still require full recall procedures and reporting.





2025 FDA Changes: New Aggressive Recall Enforcement


FDA launched significant changes in late 2024 that make recall enforcement faster and more public than ever.


What's New: Communications Pilot Program


CDRH announced a pilot to improve the timeliness of communications about corrective actions being taken by companies that the FDA believes are likely to be high-risk recalls.


Translation: FDA is moving faster to publicize your problems.


The pilot will provide early alerts of potentially high-risk device removals or corrections related to cardiovascular, gastrorenal, general hospital, obstetrics and gynecology, and urology.



Why This Crushes Traditional Timeline Planning


This pilot effort aims to increase transparency and minimize the time between the FDA's initial awareness of and public communication of potentially high-risk medical device removals or corrections.


Companies no longer have weeks to craft communications strategies. FDA is publicizing issues almost immediately.



Patient Groups Are Driving This Acceleration


Following the October 6, 2021, Patient Engagement Advisory Committee (PEAC) meeting and recommendations from PEAC members on how CDRH can further enhance our medical device recall program to better meet patients' needs, we committed to minimizing the time between the FDA's awareness and public communication about certain potentially high-risk device issues.





The FDA Recall Process: What Really Happens When Crisis Hits


Understanding the real timeline helps companies prepare for the chaos of actual recall management.


Phase 1: Problem Recognition (Hours Matter)


Companies discover issues through customer complaints, internal testing, or FDA inspection findings. Under 21 CFR 806, Medical Device Correction and Removals, manufacturers and importers are required to make a report to FDA of any correction or removal of a medical device(s) if the correction or removal was initiated to reduce a risk to health.



Phase 2: Risk Assessment and Strategy (Days, Not Weeks)


Manufacturers and distributors that initiate a voluntary recall are required to submit a recall strategy to FDA for review.


Key Requirements:

  • Immediate health hazard evaluation

  • Proposed recall classification justification

  • Customer notification timeline

  • Effectiveness monitoring plan



Phase 3: Customer Notification (Urgent Requirements)


A recall communication can be accomplished by telegrams, mailgrams, emails, electronic portals or first class letters conspicuously marked, preferably in bold red type, on the letter and the envelope: "medical device recall [or correction]". The letter and the envelope should be also marked: "urgent" for Class I and Class II recalls.



Phase 4: Public Disclosure (No Control Over Timing)


After a recall has been classified, the FDA notifies the public in the weekly Enforcement Report. With the new pilot program, this happens much faster for high-risk devices.



Phase 5: Monitoring and Termination

A recall may be terminated once FDA determines that the recalling firm has made all reasonable efforts to remove or correct the product in accordance with the recall strategy.


The FDA Recall Process: What Really Happens When Crisis Hits



FDA Recall Cost Calculator: The Real Financial Devastation


Understanding recall costs helps justify massive prevention investments and prepare for worst-case scenarios.


Immediate Financial Impact: Stock Price Massacre


A major recall can wipe out double-digit market value. McKinsey’s long-running analysis shows that at least one device company every year sees its share price fall 10 % or more after a serious quality event.


Real Bankruptcy Example: The A.H. Robins company recall and damages of their Dalkon Shield birth control device resulted in a bankruptcy filing for the massive 6,000 employee manufacturer.


If a single recall can destroy a 6,000-employee company, smaller medtech startups face existential threats.



The Hidden Costs That Destroy Companies


Long-term Reputation Damage: Reputational damages following a major event can further contribute to "serious, long-term value destruction."


Human Cost: FDA’s adverse-event database logged nearly 83,000 deaths potentially linked to medical devices between 2008 and 2017, according to an ICIJ investigation.



International Scope Multiplies Everything


Recalls of products with international distribution represented 36% of the total. In an increasingly global device market, manufacturers are more likely than ever to face global responsibility when a device fails.


International recalls face additional complexity, regulatory requirements, and legal exposure in multiple jurisdictions.





Key Takeaways: Your FDA Recall Survival Strategy


FDA recalls are becoming more frequent, more severe, and more quickly publicized. Companies that survive implement prevention-first strategies rather than reactive damage control.


If You Do Nothing Else, Do This:

  1. Audit your recall risk - software, manufacturing, labeling

  2. Build early warning systems - complaint trending, social monitoring

  3. Create rapid response protocols - every hour matters in recall situations

  4. Calculate your exposure - what would a Class I recall cost your company?

  5. Stay current with FDA's new 2025 enforcement approach


The Bottom Line: With FDA's new Communications Pilot program accelerating public disclosure and recall volumes increasing, recall prevention isn't just good business—it's the difference between market survival and catastrophic failure.


Remember: In today's medtech environment, it's not whether your company will face potential recall situations, it's whether you'll be prepared when they happen.


Don't Let FDA Recalls Destroy Your Company - Complizen's AI platform helps medtech companies prevent recalls before they happen.





Frequently Asked Questions


What triggers an FDA recall?

FDA recalls are triggered when medical devices violate federal law and pose health risks. Common triggers include software malfunctions, manufacturing defects, and labeling errors. Software issues are now the leading cause of recalls.


How long does an FDA recall take?

Class I recalls require immediate action with "urgent" customer notifications within days. FDA's new 2025 Communications Pilot reduces public disclosure time from weeks to potentially hours for high-risk devices.


Who pays for FDA recall costs?

The manufacturer pays all costs including product retrieval, notifications, and legal liability. Companies average a 10% stock price drop. Some recalls cause bankruptcy, like A.H. Robins' $500M+ Dalkon Shield case.


Can FDA force a medical device recall?

Yes, FDA can mandate recalls under 21 CFR 810 if manufacturers refuse voluntary action. While most recalls are voluntary, FDA has authority for devices posing health risks.


What's the difference between Class I, II, and III FDA recalls?

Class I: Reasonable probability of serious injury or death. Class II: May cause temporary harm. Class III: Minor violations unlikely to cause health problems. Class I recalls increased 64.76% since 2016.


How do I report a medical device problem to FDA?

Report through FDA's MedWatch system or contact your FDA district office. Manufacturers must report corrections/removals that reduce health risks under 21 CFR 806.


What happens after FDA classifies a recall?

FDA publishes recalls in the weekly Enforcement Report. The 2025 Communications Pilot provides faster public alerts for high-risk devices in cardiovascular, hospital, and urology categories.


Do all medical device recalls require product return?

No. Recalls can involve corrections (repair, relabeling) without removal, or physical return for repair/destruction. The action depends on health risk and violation type.

 
 

Never miss an update

Thanks for signing up!!

bottom of page